Researchers at Northeastern University in Boston, Massachusetts, USA, have made a breakthrough in antibiotic research.
A novel approach for growing bacteria in soil has produced 25 new antibiotics, and one has been branded “very promising.” Although soil is rich in microbes, only 1% of those can be successfully grown in a laboratory. By creating a device, the iChip, that works under the surface of the soil, researchers were able to determine that they can grow nearly half of all soil bacteria.
Kim Lewis, the lead scientist in the research and co-founder of NovoBiotic Pharmaceuticals, said: "So far 25 new antibiotics have been discovered using this method and teixobactin is the latest and most promising one. [The study shows] uncultured bacteria do harbor novel chemistry that we have not seen before. That is a promising source of new antimicrobials and will hopefully help revive the field of antibiotic discovery."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze